(877) 636-4978
ESI BIO Price Matching

Cytiva Plus Cardiomyocytes

Cytiva Plus Cardiomyocytes were derived from NIH registered human embryonic stem cell lines and are provided cryopreserved in vials containing 1x106 viable cells or 3.5x106 viable cells. Cytiva cardiomyocytes have been extensively characterized and validated as relevant models for cardiotoxic risk assessment of drug compounds and chemical entities.

For more information about our Cytiva Plus Cardiomyocytes, please complete the following form.

Request more information


* Required Fields